Patient info Open main menu

Abiraterone Zentiva 500 mg Film-Coated Tablets – patient leaflet, side effects, dosage

Last updated: · Text from the MHRA, as of · About this document

Medicine status: Prescription only (POM) Details

Medicine strength:
500 mg
Contains active substance:
Similar medicines:

Patient leaflet - Abiraterone Zentiva 500 mg film-coated tablets

1. What Abiraterone Zentiva is and what it is used for

Abiraterone Zentiva contains a medicine called abiraterone acetate. It is used to treat prostate cancer in adult men that has spread to other parts of the body. This medicine stops your body from making testosterone; this can slow the growth of prostate cancer.

When Abiraterone acetate is prescribed for the early stage of disease where it is still responding to hormone therapy, it is used with a treatment that lowers testosterone (androgen deprivation therapy).

When you take this medicine your doctor will also prescribe another medicine called prednisone or prednisolone. This is to lower your chances of getting high blood pressure, having too much water in your body (fluid retention), or having reduced levels of a chemical known as potassium in your blood.

2. What you need to know before you take Abiraterone Zentiva

Do not take Abiraterone Zentiva

  • if you are allergic to abiraterone acetate or any of the other ingredients of this medicine (listed in section 6).
  • if you are a woman, especially if pregnant. Abiraterone acetate is for use in male patients only.
  • if you have severe liver damage.
  • in combination with Ra-223 (which is used to treat prostate cancer).

Do not take this medicine if any of the above apply to you. If you are not sure, talk to your doctor or pharmacist before taking this medicine.

Warnings and precautions

Talk to your doctor or pharmacist before taking this medicine

  • if you have liver problems.
  • if you have been told you have high blood pressure or heart failure or low blood potassium (low blood potassium may increase the risk of heart rhythm problems).
  • if you have had other heart or blood vessel problems.
  • if you have an irregular or rapid heart rate.
  • if you have shortness of breath.
  • if you have gained weight rapidly.
  • if you have swelling in the feet, ankles, or legs.
  • if you have taken a medicine known as ketoconazole in the past for prostate cancer.
  • about the need to take this medicine with prednisone or prednisolone.
  • about possible effects on your bones.
  • if you have high blood sugar.

Tell your doctor if you have been told you have any heart or blood vessel conditions, including heart rhythm problems (arrhythmia), or are being treated with medicines for these conditions.

Tell your doctor if you have yellowing of the skin or eyes, darkening of the urine, or severe nausea or vomiting, as these could be signs or symptoms of liver problems. Rarely, failure of the liver to function (called acute liver failure) may occur, which can lead to death. Decrease in red blood cells, reduced sex drive (libido), muscle weakness and/or muscle pain may occur.

Abiraterone acetate must not be given in combination with Ra-223 due to a possible increase in the risk of bone fracture or death. If you plan to take Ra-223 following treatment with Abiraterone acetate and prednisone or

prednisolone, you must wait 5 days before starting treatment with Ra-223.

If you are not sure if any of the above apply to you, talk to your doctor or pharmacist before taking this medicine.

Blood monitoring

Abiraterone acetate may affect your liver, and you may not have any symptoms. When you are taking this medicine, your doctor will check your blood periodically to look for any effects on your liver.

Children and adolescents

This medicine is not for use in children and adolescents. If Abiraterone acetate is accidentally ingested by a child or adolescent, go to the hospital immediately and take the package leaflet with you to show to the emergency doctor.

Other medicines and Abiraterone acetate Ask your doctor or pharmacist for advice before taking any medicine.

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. This is important because Abiraterone acetate may increase the effects of a number of medicines including heart medicines, tranquilisers, some medicines for diabetes, herbal medicines (e.g. St. John’s Wort) and others. Your doctor may want to change the dose of these medicines. Also, some medicines may increase or decrease the effects of Abiraterone acetate. This may lead to side effects or to this medicine not working as well as it should.

Androgen deprivation treatment may increase the risk of heart rhythm problems. Tell your doctor if you are receiving medicine

  • used to treat heart rhythm problems (e.g. quinidine, procainamide, amiodarone and sotalol).
  • known to increase the risk of heart rhythm problems [e.g. methadone (used for pain relief and part of drug addiction detoxification), moxifloxacin (an antibiotic), antipsychotics (used for serious mental illnesses)].

Tell your doctor if you are taking any of the medicines listed above.

Abiraterone acetate with food

Pregnancy and breast-feeding

Abiraterone acetate is not for use in women.

Women who are pregnant or who may be pregnant should wear gloves if they need to touch or handle Abiraterone acetate.

  • This medicine may cause harm to the unborn child if it is taken by women who are pregnant.
  • If you are having sex with a woman who can become pregnant, use a condom and another effective birth control method.
  • If you are having sex with a pregnant woman, use a condom to protect the unborn child.

Driving and using machines

This medicine is not likely to affect your ability to drive and use any tools or machines. Abiraterone acetate contains lactose and sodium

This medicine contains lactose (a type of sugar). If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine.

This medicinal product also contains less than 1 mmol (or 23 mg) sodium per tablet, that is to say essentially “sodium-free”.

3. How to take Abiraterone Zentiva

Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.

How much to take

The recommended dose is 1,000 mg (2 tablets) once a day.

Taking this medicine

  • Take this medicine by mouth.
  • Do not take Abiraterone acetate with food.
  • Take Abiraterone acetate at least 1 hour before or at least 2 hours after eating (see section 2, “Abiraterone acetate with food”).
  • Swallow the tablets whole with water.
  • Do not break the tablets.
  • Abiraterone acetate is taken with a medicine called prednisone or prednisolone. Take the prednisone or prednisolone exactly as your doctor has told you.
  • You need to take prednisone or

    prednisolone every day while you are taking Abiraterone acetate.

  • The amount of prednisone or prednisolone you take may need to change if you have a medical emergency. Your doctor will tell you if you need to change the amount of prednisone or prednisolone you take. Do not stop taking prednisone or prednisolone unless your doctor tells you to.

Your doctor may also prescribe other medicines while you are taking Abiraterone acetate and prednisone or prednisolone. If you take more Abiraterone acetate than you should

If you take more Abiraterone acetate than you should, talk to your doctor or go to a hospital immediately.

If you forget to take Abiraterone acetate

If you forget to take Abiraterone acetate or prednisone or prednisolone, take your usual dose the following day. If you forget to take Abiraterone acetate or prednisone or prednisolone for more than 1 day, talk to your doctor without delay.

If you stop taking Abiraterone acetate

Do not stop taking Abiraterone acetate or prednisone or prednisolone unless your doctor tells you to.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Stop taking Abiraterone acetate and see a doctor immediately if you notice any of the following:

  • Muscle weakness, muscle twitches or a pounding heart beat (palpitations). These may be signs that the level of potassium in your blood is low.

Other side effects include:

Very common (may affect more than 1 in 10 people):

Fluid in your legs or feet, low blood potassium, liver function test increases, high blood pressure, urinary tract

infection, diarrhoea.

Common (may affect up to 1 in 10 people): High fat levels in your blood, chest pain, irregular heart beat (atrial fibrillation), heart failure, rapid heart rate, severe infections called sepsis, bone fractures, indigestion, blood in urine, rash.

Uncommon (may affect up to 1 in 100 people): Adrenal gland problems (related to salt and water problems), abnormal heart rhythm (arrhythmia), muscle weakness and/or muscle pain.

Rare (may affect up to 1 in 1,000 people): Lung irritation (also called allergic alveolitis), failure of the liver to function (also called acute liver failure).

Not known (frequency cannot be estimated from the available data):

Heart attack, changes in ECG –

electrocardiogram (QT prolongation), and serious allergic reactions with difficulty swallowing or breathing, swollen face, lips, tongue or throat, or an itchy rash.

Bone loss may occur in men treated for prostate cancer. Abiraterone acetate in combination with prednisone or prednisolone may increase bone loss.

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.

5. How to store Abiraterone Zentiva

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the carton and the blister. The expiry date refers to the last day of that month.

This medicinal product does not require any special storage conditions.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6. Contents of the pack and other information

What Abiraterone Zentiva contains

  • The active substance is abiraterone acetate. Each film-coated tablet contains 500 mg abiraterone acetate.

    • The other ingredients are:

      Tablet core: Lactose, monohydrate; Cellulose, Microcrystalline; Croscarmellose sodium; Sodium lauryl sulphate; Hypromellose; Magnesium stearate; Silica, colloidal.

      Film-coating: Polyvinyl alcohol (E1203); Macrogol 3350; Talc (E553b); Titanium dioxide (E171); Iron oxide red (E172); Iron oxide black (E172).

What Abiraterone Zentiva looks like and contents of the pack

Abiraterone acetate film-coated tablets are purple to brown film-coated tablets, oblong 20×10 mm.

Abiraterone acetate film-coated tablets are in PVC/PVDC90 foil and an aluminium foil blisters.

The pack contains 56 or 60 film-coated tablets.

Not all pack sizes may be marketed. Marketing Authorisation Holder and Manufacturer

Marketing Authorisation Holder

Zentiva Pharma UK Limited

12 New Fetter Lane

London

EC4A 1JP

United Kingdom

Manufacturer

ZENTIVA k.s.

U kabelovny 130, Dolní Měcholupy, 10237 Prague 10,

Czech Republic.

This leaflet was last revised in July 2025

ZV/739 47

GENERAL INFO:
PM CODE:ZV/739 47
PRODUCT NAME:ABIRATERONE 500MG TABCO BL4X14 GB
SAP ID / GMID:11011224
AW VERSION:V1
CREATION DATE:03.07.2025
AW BY:GD
SUPPLIER:N/A
REASON OF REVISION:
PRG - see reason for change in Vista
FORMAT (size):160 × 400 mm
(3936) 11000010111; L - 2, C - 2, R - 3
FONT + MIN. SIZE:Helvetica Neue LT W1G 9 pt
MATERIAL TYPE (TS):N/A
COLOURS: [ 1 ]TECH. COLOURS: [ 1 ]

Fiber direction This line = the place a bend of a leaflet direction of Code reading

direction of Code reading

Infobox check
PM code (acc. Vista)OK
Product name (acc. Vista)OK
SAP ID / GMID (acc. Vista)OK
Colors (add only used colors)OK
Technical check
OK
OK
Leatus code: position and orientationOK
value of codeOK
Design check
Corresponds to: leaflet design manualOK
registered mockupN/A
OK
OK
Logo placement (check if proper logo is used)OK
Legislation check
OK
Line spacing (minimum line spacing is 8.5 pt)OK
Text according to: QRD (text used acc. Vista)N/A
Annotated PDF (acc. Vista)OK

New version check

V1

Update infobox (version and other data if needed)OK

Applied corrections (check if only requested corrections have been applied)

OK

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 17780/1040

Last revision stated in the text: July 2025 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Abiraterone Zentiva 500 mg film-coated tablets

Prescription needed? Yes, prescription-only medicine (POM)
Active substance Abiraterone
Strength 500 mg
Pharmaceutical form Oral tablet
Purple to brown oblong film-coated tablets, with dimensions 20×10 mm.
How is it taken Oral
Excipients Lactose, monohydrate Cellulose, Microcrystalline Croscarmellose sodium Sodium lauryl sulphate Hypromellose, Magnesium stearate, Silica, colloidal, Polyvinyl alcohol (E1203) Macrogol 3350, Talc (E553b), Titanium dioxide (E171) Iron oxide red (E172) Iron oxide black (E172)
Pack sizes 56 tablet
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life 3 years
Storage This medicinal product does not require any special storage conditions.
Drug group (ATC) Endocrine therapy, other hormone antagonists and related agents
  1. L Antineoplastic and immunomodulating agents
    1. L02 Endocrine therapy antineoplastic and immunomodulating agents
      1. L02B Hormone antagonists and related agents
        1. L02BX Other hormone antagonists and related agents
          1. L02BX03 abiraterone
Marketing authorisation PL 17780/1040 (first authorised 12 October 2021)
Marketing authorisation holder Zentiva Pharma UK Limited
Codes GTIN 8594739247772 · BNF 08030402

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.2.0 of 19 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.